rs34137556
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The ENST00000264335.13(YWHAE):c.282G>A(p.Lys94=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0295 in 1,585,946 control chromosomes in the GnomAD database, including 824 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.023 ( 48 hom., cov: 31)
Exomes 𝑓: 0.030 ( 776 hom. )
Consequence
YWHAE
ENST00000264335.13 synonymous
ENST00000264335.13 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.193
Genes affected
YWHAE (HGNC:12851): (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 100% identical to the mouse ortholog. It interacts with CDC25 phosphatases, RAF1 and IRS1 proteins, suggesting its role in diverse biochemical activities related to signal transduction, such as cell division and regulation of insulin sensitivity. It has also been implicated in the pathogenesis of small cell lung cancer. Two transcript variants, one protein-coding and the other non-protein-coding, have been found for this gene. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 17-1361991-C-T is Benign according to our data. Variant chr17-1361991-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 260034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-1361991-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.193 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.023 (3481/151374) while in subpopulation NFE AF= 0.0348 (2365/67966). AF 95% confidence interval is 0.0336. There are 48 homozygotes in gnomad4. There are 1596 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3481 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YWHAE | NM_006761.5 | c.282G>A | p.Lys94= | synonymous_variant | 3/6 | ENST00000264335.13 | NP_006752.1 | |
YWHAE | NR_024058.2 | n.427G>A | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YWHAE | ENST00000264335.13 | c.282G>A | p.Lys94= | synonymous_variant | 3/6 | 1 | NM_006761.5 | ENSP00000264335 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0230 AC: 3483AN: 151256Hom.: 48 Cov.: 31
GnomAD3 genomes
AF:
AC:
3483
AN:
151256
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0237 AC: 5358AN: 225938Hom.: 80 AF XY: 0.0254 AC XY: 3132AN XY: 123232
GnomAD3 exomes
AF:
AC:
5358
AN:
225938
Hom.:
AF XY:
AC XY:
3132
AN XY:
123232
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0302 AC: 43357AN: 1434572Hom.: 776 Cov.: 30 AF XY: 0.0309 AC XY: 22031AN XY: 713542
GnomAD4 exome
AF:
AC:
43357
AN:
1434572
Hom.:
Cov.:
30
AF XY:
AC XY:
22031
AN XY:
713542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0230 AC: 3481AN: 151374Hom.: 48 Cov.: 31 AF XY: 0.0216 AC XY: 1596AN XY: 74028
GnomAD4 genome
AF:
AC:
3481
AN:
151374
Hom.:
Cov.:
31
AF XY:
AC XY:
1596
AN XY:
74028
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
41
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at